Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study

BACKGROUND: Corticosteroids (CSs), specifically dexamethasone (DEX), are the treatment of choice for severe acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia (CARDS). However, data from both ARDS and relatively small CARDS clinical trials have suggested improved outcomes with meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Kellogg, Dean, Gutierrez, G. Christina, Small, Clay E., Stephens, Benjamin, Sanchez, Paloma, Beg, Moezzullah, Keyt, Holly L., Restrepo, Marcos I., Attridge, Rebecca L., Maselli, Diego J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936170/
https://www.ncbi.nlm.nih.gov/pubmed/36818803
http://dx.doi.org/10.1177/20499361231153546

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936170/
https://www.ncbi.nlm.nih.gov/pubmed/36818803
http://dx.doi.org/10.1177/20499361231153546

Ejemplares similares